<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04301427</url>
  </required_header>
  <id_info>
    <org_study_id>PO20019</org_study_id>
    <nct_id>NCT04301427</nct_id>
  </id_info>
  <brief_title>Smallest Significant Value in Osteodensitomery in an Obese Population</brief_title>
  <acronym>PPVS-ob</acronym>
  <official_title>Smallest Significant Value in Osteodensitomery in an Obese Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determined the smallest significant value in osteodensitometry in&#xD;
      obese population. The study population will be divided in 3 groups according to their BMI.&#xD;
&#xD;
      Bone mineral density will be measured twice in osteodensitometry, then the smallest&#xD;
      significant value will be determined.&#xD;
&#xD;
      Our hypothesis is that the smallest significant value that we use in an non-obese population&#xD;
      can be different in an obese population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to determined the smallest significant value in osteodensitometry in&#xD;
      obese population.&#xD;
&#xD;
      There will be at least 120 patient included. The study population will be divided in 3 groups&#xD;
      according to their BMI : the first group has a BMI between 30 and 35 kg/cm² ; the second&#xD;
      group has a BMI between 35 et 40 kg/cm² ; and the third group has a BMI over 40 kg/cm².&#xD;
&#xD;
      Patients will be referred by their doctors (rheumatologist and others) to evaluate their bone&#xD;
      mineral density in osteodensitometry at CHU of Reims. Patients will be informed of the aim of&#xD;
      the study by the prescriptor of the osteodensitometry.&#xD;
&#xD;
      The osteodensitometry will be executed by a nurse. Patients will have to complete a&#xD;
      questionnaire about their medical history and their medications.&#xD;
&#xD;
      Bone mineral density will be measured twice in osteodensitometry, at the lumbar spine, the&#xD;
      hip and the femur. This exam lasts approximately 40 minutes.&#xD;
&#xD;
      Then the smallest significant value will be determined by comparing each measure for every&#xD;
      patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Actual">August 31, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>osteodensitometry in obese population</measure>
    <time_frame>Day 1</time_frame>
    <description>smallest significant value in osteodensitometry in obese population</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>osteodensitometry in obese population with BMI between 30 and 35 kg/cm²</measure>
    <time_frame>Day 1</time_frame>
    <description>smallest significant value in osteodensitometry in obese population with BMI between 30 et 35 kg/cm²</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>osteodensitometry in obese population with BMI between 35 and 40 kg/cm²</measure>
    <time_frame>Day 1</time_frame>
    <description>smallest significant value in osteodensitometry in obese population with BMI between 35 et 40 kg/cm²</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>osteodensitometry in obese population with BMI over 40 kg/cm²</measure>
    <time_frame>Day 1</time_frame>
    <description>Smallest significant value in osteodensitometry in obese population with BMI over 40 kg/cm²</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Obese patient</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bone mineral density</intervention_name>
    <description>Bone mineral density will be measured twice in all included patients.</description>
    <arm_group_label>Obese patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :&#xD;
&#xD;
          -  Major patients&#xD;
&#xD;
          -  Patients referred to the CHU of Reims to make an osteodensitometric evaluation of&#xD;
             their bone mineral density&#xD;
&#xD;
          -  BMI &gt; 30 kg/cm²&#xD;
&#xD;
          -  Patient affiliated to a health insurance plan&#xD;
&#xD;
          -  Patients who have signed informed consent&#xD;
&#xD;
        Exclusion criteria :&#xD;
&#xD;
          -  Minor patients&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Patients protected by the law&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 6, 2020</study_first_submitted>
  <study_first_submitted_qc>March 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bone density</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>Osteopenia</keyword>
  <keyword>Obesity</keyword>
  <keyword>OSteodensitometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

